TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
BDSX

Biodesix Inc

Healthcare · Diagnostics & Research

30.40$ +4.5% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement BDSX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
21.6% 24.7% 48.3% 56.0% 37.0% 26.5% 21.8% 18.9%
78.4% 75.3% 51.7% 44.0% 63.0% 73.5% 78.2% 81.1%
40.1% 42.6% 23.7% 23.5% 34.3% 20.3% 13.4% 13.6%
126.8% 124.8% 76.5% 92.7% 160.8% 138.0% 112.8% 98.9%
166.8% 184.2% 102.1% 119.1% 195.3% 157.7% 126.5% 112.5%
-114.8% -108.9% -50.3% -75.1% -132.4% -84.2% -48.4% -31.4%
14.3% 12.3% 16.7% 8.3% 21.1% 19.4% 11.6% 8.7%
-128.1% -125.1% -68.8% -79.2% -171.3% -106.2% -60.2% -39.8%
1.0% 2.6% 11.2% 2.4% 39.1% 10.9% – –
-128.1% -125.1% -68.8% -79.2% -171.3% -106.2% -60.2% -39.8%
-105.3% -101.5% -45.8% -65.1% -134.9% -75.6% -41.0% -24.8%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?